Optimism is high in just about every major-league camp this time of year (sorry, Rockies), and that’s been especially true around the Mariners this spring. Expectations are as great as they’ve ever ...

Timothy Graham receives funding from the Australian Research Council (ARC) for the Discovery Project, 'Understanding and Combatting "Dark Political Communication"'. A new study published today in ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

Samsung announced its newest portable projector ahead of its First Look showcase at CES 2026, but you might have been a little confused as to what’s changed. The company says the Freestyle+ is nearly ...

To commemorate America’s 250th birthday in 2026, the Washington Monument will have a projection show and an illumination of a 250-foot birthday candle beginning on New Year’s Eve. It is part of a ...

Instagram is introducing a new tool that lets you see and control your algorithm, starting with Reels, the company announced on Wednesday. The new tool, called “Your Algorithm,” lets you view the ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

The average Social Security retirement beneficiary is expected to receive a monthly payment of about $2,064 in 2026, based on the most recent data provided by the Social Security Administration. But ...

As the world races to build artificial superintelligence, one maverick bioengineer is testing how much unprogrammed intelligence may already be lurking in our simplest algorithms to determine whether ...

Low intensity exercise encompasses activities that aren’t challenging and don’t increase your heart rate much. It can still provide health benefits, particularly when done more often. Exercise is ...

Intensity Therapeutics (INTS), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase 1/2 results on its candidate for metastatic or refractory cancers, INT230-6. The asset ...